CIK 0001652130 · Large accelerated filer
Intellia Therapeutics, Inc.
Sign in to watch- Ticker
- NTLA
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 364785571
- Phone
- 857-285-6200
- Business address
- 400 TECHNOLOGY SQUARE, SUITE 100, CAMBRIDGE, MA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $417,899
- in 3 filings, $395K under 10b5-1 plans
Net −$417,899. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 7 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-12-07 | Bermingham Nessan President & CEO | Sale | −27,566 | $21.46 | $591K | 552,393 |
| 2017-12-06 | Bermingham Nessan President & CEO | Sale | −99,033 | $20.28 | $2.0M | 696,000 |
| 2017-12-06 | Bermingham Nessan President & CEO | Sale | −12,467 | $20.84 | $260K | 683,533 |
| 2017-11-03 | Bell Graeme EVP, Chief Financial Officer | Grant or award | +5,000 | $22.04 | $110K | 13,400 |
| 2017-09-13 | Caribou Biosciences, Inc. 10% owner | Sale | −1,048,846 | 4,545,000 | ||
| 2017-07-25 | Verwiel Frank Director | Grant or award · Stock Option (right to buy) | +38,000 | 38,000 | ||
| 2017-07-25 | Slaoui Moncef Director | Grant or award · Stock Option (right to buy) | +38,000 | 38,000 | ||
| 2017-07-11 | FORMELA JEAN FRANCOIS Director | Sale | −80,000 | $16.07 | $1.3M | 3,579,788 |
| 2017-07-11 | Atlas Venture Fund IX, L.P. 10% owner | Sale | −80,000 | $16.07 | $1.3M | 3,579,788 |
| 2017-07-10 | FORMELA JEAN FRANCOIS Director | Sale | −40,000 | $16.17 | $647K | 3,659,788 |
| 2017-07-10 | Atlas Venture Fund IX, L.P. 10% owner | Sale | −40,000 | $16.17 | $647K | 3,659,788 |
| 2017-07-07 | FORMELA JEAN FRANCOIS Director | Sale | −30,000 | $16.77 | $503K | 3,699,788 |
| 2017-07-07 | Atlas Venture Fund IX, L.P. 10% owner | Sale | −30,000 | $16.77 | $503K | 3,699,788 |
| 2017-06-02 | DORSA CAROLINE Director | Grant or award | +5,000 | $12.42 | $62K | 5,000 |
| 2017-06-02 | Bell Graeme EVP, Chief Financial Officer | Grant or award | +8,400 | $12.37 | $104K | 8,400 |
| 2017-06-01 | KARSEN PERRY A Director | Grant or award | +5,000 | $11.99 | $60K | 5,000 |
| 2017-06-01 | Rivera Jose E EVP, General Counsel & Ops | Grant or award | +8,400 | $12.03 | $101K | 8,994 |
| 2017-06-01 | LEONARD JOHN M. EVP, R&D | Grant or award | +7,800 | $12.06 | $94K | 7,800 |
| 2017-06-01 | LEONARD JOHN M. EVP, R&D | Grant or award | +600 | $12.09 | $7K | 8,400 |
| 2017-06-01 | Bermingham Nessan President & CEO | Grant or award | +8,400 | $11.95 | $100K | 795,033 |
Page 36 of 40 · 783 trades